Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
PRILOZI
Volume 44 (2023): Issue 3 (December 2023)
Open Access
Effectiveness of Ropeginterferon Alfa-2B in High-Risk Patients with Philadelphia Chromosome Negative Myeloproliferative Neoplasms– Evaluation of Clinicohaematologic Response, and Safety Profile: Single Centre Experience
Marija Popova-Labachevska
Marija Popova-Labachevska
,
Milche Cvetanoski
Milche Cvetanoski
,
Nevenka Ridova
Nevenka Ridova
,
Sanja Trajkova
Sanja Trajkova
,
Simona Stojanovska-Jakimovska
Simona Stojanovska-Jakimovska
,
Tara Mojsovska
Tara Mojsovska
,
Zlate Stojanoski
Zlate Stojanoski
,
Aleksandra Pivkova-Veljanovska
Aleksandra Pivkova-Veljanovska
and
Irina Panovska-Stavridis
Irina Panovska-Stavridis
| Dec 18, 2023
PRILOZI
Volume 44 (2023): Issue 3 (December 2023)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 18, 2023
Page range:
57 - 62
DOI:
https://doi.org/10.2478/prilozi-2023-0047
Keywords
Essential Thrombocythemia
,
Polycythemia Vera
,
Primary Myelofibrosis
,
myeloproliferative neoplasms
,
ropeginterferon alfa-2b
© 2023 Marija Popova-Labachevska et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Marija Popova-Labachevska
University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje
RN Macedonia
Milche Cvetanoski
University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje
RN Macedonia
Nevenka Ridova
University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje
RN Macedonia
Sanja Trajkova
University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje
RN Macedonia
Simona Stojanovska-Jakimovska
University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje
RN Macedonia
Tara Mojsovska
University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje
RN Macedonia
Zlate Stojanoski
University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje
RN Macedonia
Aleksandra Pivkova-Veljanovska
University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje
RN Macedonia
Irina Panovska-Stavridis
University clinic of hematology, Faculty of Medicine, Ss. Cyril and Methodius University in Skopje
RN Macedonia